By Juan F. Roman You know how the diagnostics industry relies on the “razor blade” model: give the instrument for free and make the profit with the consumable. The gross profit in consumables is often more than 90% and absorbs the expensive cost of developing the...
Sixth Acquisition Extends Veranex Lead in MedTech Industry Services
Veranex expands global capabilities for human-centered design, innovation, and strategy RALEIGH, N.C.; Dec. 7, 2021 – Veranex, the only global, tech-enabled product development services provider focused on the medical technology industry, today announced its latest...
Veranex Announces Acquisition of IMMR
RALEIGH, N.C.; Oct. 12, 2021 – Veranex, the first concept-to-commercialization global service provider dedicated to the MedTech industry, today announced the acquisition of IMMR, a leading preclinical science organization that provides preclinical research, pathology...
Veranex Announces Acquisition of Experien Group
RALEIGH, N.C.; August 3, 2021 – Veranex the first concept-to-commercialization global service provider dedicated to the medtech industry, today announced the acquisition of Experien Group, a leading provider of a full range of regulatory, quality, and clinical...
Veranex Announces Investment From Summit Partners to Form Comprehensive Concept-to-Commercialization MedTech Services Company
RALEIGH, N.C.; June 16, 2021 – Veranex today announced the formation of the first concept-to-commercialization global service provider dedicated to the medtech industry. Formed in partnership with global growth investor Summit Partners, the Veranex platform is...
Quartesian Signs Global Medical Technology Company to Multiyear Clinical Data Management Services Agreement
PRINCETON, N.J., April 13, 2021 — Quartesian, a multinational clinical research organization (CRO) serving the biopharmaceutical and medical device industries, today announced a multiyear agreement with a leading portfolio medical technology company. Under the...